Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Gao, Hui-Ming, Zhang, Feng, Zhou, Hui, Kam, Wayneho, Wilson, Belinda, Hong, Jau-Shyong·2011·Environmental Health Perspectives
DOI 10.1289/ehp.1003013

Cited by (355)

Items 301–355 of 355

  1. Understanding the Pre-Clinical Stages of Parkinson’s Disease: Where Are We in Clinical and Research Settings?
    Camilla Dalla Verde, Sri Delasmi Jayanti, Korri Elvanita El-Khobar, John A. Stanford, Claudio Tiribelli, Silvia Gazzin · 2025 · International Journal of Molecular Sciences
  2. Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model
    Rachel J. Boyd, A Ra Kho, Sarah A. McClymont, Stacie K. Loftus, Han Seok Ko, Andrew S. McCallion · 2026 · Brain
  3. Potential role of splice junctions of α-synuclein isoforms in the activation of T-cells: Implications for Parkinson's disease
    Shweta Kaul, Aravind Vulli, Shasi V. Kalivendi · 2026 · Cellular Signalling
  4. Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk
    Zhi-Lin Wang, Tracie R. Baker, Ashley J. Malin · 2026 · Current Research in Toxicology
  5. The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence
    Francisco J. Pan-Montojo, Kai F. Loewenbrück, Heinz Reichmann · 2020 · Elsevier eBooks
  6. The Effect of Systemic Inflammation on Cognitive Function and Neurodegenerative Disease
    Colm M. Cunningham, Donal Skelly · 2021 · Cambridge University Press eBooks
  7. NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Журнал высшей нервной деятельности им И П Павлова
  8. Neuroinflammation, glymphatic system, and Parkinson's disease
    Sohaila Mohammed Salah Saleh, Nada Nasser, Engy K. Tharwat, Tasneem Elbehiry, Hagar Ismail Helmy · 2024 · Elsevier eBooks
  9. Putative neuroprotective compounds in in vitro models of dopaminergic neurodegeneration
    Bernardino Ossola · 2011 · Työväentutkimus Vuosikirja
  10. "A GREAT PERTURBATION IN NATURE" : PARKINSON'S DISEASE AND SLEEP DISORDERS
    Ari Ylikoski · 2016 · Työväentutkimus Vuosikirja
  11. Modelling Parkinson’s Disease Pre-Clinically: A Novel Virus-Fibril Inducible Mouse Model Exploring Disease Characteristics and Therapeutic Intervention via Metabotropic Glutamate Receptor 5 Negative Allosteric Modulation
    Samantha C. Bureau · 2022 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  12. The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
    Singh, Priyanka · 2013 · uO Research (University of Ottawa)
  13. Considerations on the role of environmental toxins in idiopathic Parkinson's disease
    Francisco J. Pan-Montojo, Heinz Reichmann · 2014
  14. Aging and Microglial Activation in Neurodegenerative Diseases
    Esteban A. Oyarzabal, Yen‐Yu Ian Shih, Jau‐Shyong Hong · 2016 · Oxidative stress in applied basic research and clinical practice
  15. Inflammation-Mediated Neurodegeneration: Models, Mechanisms, and Therapeutic Interventions for Neurodegenerative Diseases
    Hui‐Ming Gao, Yun Gao, Dezhen Tu, Yue Liu, Hui Zhou, Jau‐Shyong Hong · 2017 · Wiley-VCH eBooks
  16. Cognitive Movement Disorders, Gut Dysbiosis and Skin Diseases
    Chan Kam Tim Michael · 2018 · Biomedical Journal of Scientific & Technical Research
  17. The Impact of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency in a Paraquat Mouse Model of Parkinson’s Disease
    Lauren Murray · 2018
  18. Alpha-synuclein spreading pathology in Parkinson's disease: the influence of iron and the Rho-kinase inhibitor fasudil
    Karina Joppe · 2020 · eDiss (Georg-August-Universität Göttingen)
  19. Divergence in Neuronal Calcium Dysregulation in Brain Aging and Animal Models of AD
    Adam O. Ghoweri · 2020 · UKnowledge (University of Kentucky)
  20. Gut Microbiota in Brain diseases
    Mahmoud Salami · 2021 · Elsevier eBooks
  21. Resveratrol and brain mitochondria
    Patrícia Coelho, Ana Cristina Rego · 2021 · Elsevier eBooks
  22. Role of caspases and apoptosis in Parkinson's disease
    Anil Gupta · 2021 · Elsevier eBooks
  23. Disturbances in Redox Homeostasis in the Ageing Brain
    Sambe Asha Devi, T. B. Basavaraju · 2021 · Healthy ageing and longevity
  24. Efficacy of Phytochemicals and Natural Products in the Management/Treatment of Neurodegenerative Diseases
    Johnson Olaleye Oladele, Oluwaseun Titilope Oladele, Taiwo Scholes Adewole, Oyedotun M. Oyeleke, Adenike Temidayo Oladiji · 2022 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  25. LRRK2-G2019S Synergizes With Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation That Precede Nigrostriatal Degeneration
    Bianca Marchetti, Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi et al. · 2022 · Research Square
  26. Novel Theranostics for Parkinson's Disease
    Benjamin William Schlichtmann · 2021
  27. Effects of acupuncture on Parkinson's disease-related constipation and roles of gut microbial ecology: study protocol for a randomized controlled clinical trial
    Suying Lei, Jingqi Fan, Jingyi Quan, Yinjia Li, Minjun Cen, Xiaoyan Xu, Xin Liu, Shunan Wu, Kaihao Liao, Shumin Lin et al. · 2024 · Research Square
  28. Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies (Review)
    Nina P. Trubitsina, Anton B. Matiiv, Tatyana M. Rogoza, Anna A. Zudilova, Mariya D. Bezgina, Galina A. Zhouravleva, Stanislav A. Bondarev · 2024 · Biochemistry (Moscow)
  29. In vivo and in silico alpha-synuclein propagation dynamics: The role of genotype, epicentre, and connectivity
    Stéphanie Tullo, Janice Park, Shady Rahayel, Daniel Gallino, Megan Park, Kristie Mar, Ying‐Qiu Zheng, Esther del Cid‐Pellitero, Edward A. Fon, Wen Luo et al. · 2025 · eLife
  30. The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
    Ankita Das, Vani Vivek, Palok Aich · 2025 · Discover Immunity.
  31. Reduced levels of nitrated α-synuclein in the protective effect of harpagoside on rotenone-induced cellular models of Parkinson’s disease
    Juan Lang, Zhongkui Xiong · 2025 · Frontiers in Cell and Developmental Biology
  32. From Kitchen Spice to Neuroprotector: The Role of 6-Shogaol in Parkinson’s Disease Management
    Jiahui Jin, Xiran Li, Yunxi Wang, Zishu Yan, Airong Lv, Yanjun Zhang, Pengwei Zhuang, Hong Guo · 2025 · Journal of Agricultural and Food Chemistry
  33. Advanced age and lipopolysaccharide influence behavioral and neurodegenerative features in LRRK2 G2019S knock-in mice
    Anuroopa Dinesh, Teresa Fortin, Hongyu Sun, Shawn P. Hayley · 2025 · Behavioural Brain Research
  34. Additional file 13 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  35. Additional file 8 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  36. Additional file 9 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  37. Additional file 7 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  38. Additional file 1 of Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
    Di Liu, Guo, Jian-Jun, Su, Ji-Hui, Alexander Svanbergsson, Yuan, Lin, Caroline Haikal, Li, Wen, Gunnar K. Gouras, Jiayi Li · 2021 · Figshare
  39. Additional file 5 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  40. Additional file 1 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2023 · Figshare
  41. Additional file 3 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  42. Additional file 6 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  43. Additional file 2 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  44. Additional file 11 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, El-Agnaf, Omar M. A., Abid Oueslati · 2024 · Figshare
  45. Additional file 4 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  46. Additional file 12 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  47. Additional file 10 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
    Morgan Bérard, Laura Martínez-Drudis, Razan Sheta, Omar M. A. El‐Agnaf, Abid Oueslati · 2024 · Figshare
  48. Air pollution and neurotoxicity: The role of environmental pollutants in movement disorders
    Kimberly C. Paul, Jeff M. Bronstein · 2026 · International review of movement disorders
  49. Étude moléculaire de la propagation de l’agrégation de l’alpha-synucléine dans un modèle transgénique de la maladie de Parkinson : impact de la surexpression de la beta-synucléine à l’aide de vecteurs viraux adéno-associés (AAV)
    Dorian Sargent · 2018 · theses.fr (ABES)
  50. Dietary restriction as a potential neuroprotective intervention: a narrative review of its impact on neuroinflammation across neurodegenerative diseases and other neurological disorders
    Buhui Liu, Yating Zhang, Wenxin Deng, Yi Zhou, Yuhan Cao, Lie Xiong, Ruoyi Shen, Simon Ming-Yuen Lee, Jinsong Bian, Yaqi Bian · 2026 · Frontiers in Nutrition
  51. GLP-1 analogs restore inflammatory, mitochondrial and intercellular signaling networks in the Snca G51D/G51D knock-in mouse model of Parkinson’s disease
    Bhupesh Vaidya, Yan Li, Young Doo Kim, Cameron Osterman, Jean‐Pierre Revelli, Huda Yahya Zoghbi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Astrocytic Redox Homeostasis as a Metabolic Modulator of DNA Damage and Repair in the Ischemic Penumbra
    Renata Kołodziejska, Antoni Godlewski, Agnieszka Tafelska‐Kaczmarek, Julia Kuk, Magdalena Moritz, Krzysztof Sergot, Natalia Kurhaluk, Галина Михайлівна Ткаченко, Alina Woźniak · 2026 · Cells
  53. Serum miR-423–5p discriminates patients with Parkinson's disease from healthy individuals and is associated with severity and the risk of cognitive dysfunction
    Pingting Chen, Wei Wang, Hengping Chen, Fang Ye · 2026 · Clinical Neurology and Neurosurgery
  54. Zebrafish models provide insight into the biological classification of Parkinson's disease
    Wael Mohamed, Tiago F. Outeiro · 2026 · Elsevier eBooks
  55. Spatiotemporal Changes in the Cytokine Profile in the Brain of A53T Transgenic Mice, a Model of Parkinson’s Disease
    Альперина Елизавета Лазаревна, Galina V. Idova, Svetlana Ya. Zhanaeva, Maria A. Tikhonova, Margarita M. Gevorgyan, Lyubomir I. Aftanas · 2026 · Biochemistry (Moscow)